Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Eight Years Experience in External Quality Assessment Scheme (EQAS) for Peripheral Blood Morphology

Gabriela Gutierrez, Anna Merino, MD, PhD, Alicia Domingo, MD, PhD, Josep M Jou, Joan C Reverter

Blood (2008) 112 (11): 4684.

https://doi.org/10.1182/blood.V112.11.4684.4684

Published: 2008

Journal Articles

Analysis of Cytogenetic Abnormalities and Their Prognostic Impact in a Series of 145 Mantle Cell Lymphoma Cases with An Abnormal Karyotype.

Blanca Espinet, PhD, Salaverría Itziar, PhD, Sílvia Beà, PhD, Neus Ruiz-Xivillé, Olga Balagué, MD, Marta Salido, Dolors Costa, PhD, Ana E Rodriguez, Juan LuíS. García, PhD, JesúS. M.ª Hernández-Rivas, MD, PhD, M.ª José Calasanz, PhD, Ana M Ferrer, MD, PhD, Antonio Salar, MD, PhD, Ana Carrió, PhD, Natividad Polo, Jose Antonio García-Marco, MD, PhD, Alicia Domingo, MD, Eva González-Barca, MD, PhD, Vicenç Romagosa, MD, Isabel Marugán, Armando López-Guillermo, MD, PhD, Fuensanta Millá, MD, José Luís Mate, MD, PhD, Elisa Luño, MD, PhD, Carmen Sanzo, MD, PhD, Rosa Collado, MD, PhD, Isabel Oliver, Sebastià Monzó, MD, Antonio Palacín, MD, Teresa González, Francesc Sant, MD, Ramon Salinas, MD, PhD, Mª Teresa Ardanaz, MD, Llorenç Font, MD, PhD, Lourdes Escoda, MD, Lourdes Florensa, MD, PhD, Elias Campo, MD, PhD, Sergi Serrano, MD, PhD, Francesc Solé, PhD

Blood (2008) 112 (11): 1765.

https://doi.org/10.1182/blood.V112.11.1765.1765

Published: 2008

Journal Articles

MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells

Llorenç Coll-Mulet, Daniel Iglesias-Serret, Antonio F. Santidrián, Ana M. Cosialls, Mercè de Frias, Esther Castaño, Clara Campàs, Montserrat Barragán, Alberto Fernández de Sevilla, Alicia Domingo, Lyubomir T. Vassilev, Gabriel Pons, Joan Gil

Blood (2006) 107 (10): 4109–4114.

https://doi.org/10.1182/blood-2005-08-3273

Published: 2006

Includes: Supplemental data

Journal Articles

MDM2 Antagonists Activate p53 and Synergize with Genotoxic Drugs To Induce Apoptosis in B-Cell Chronic Lymphocytic Leukemia Cells but Not in T Cells.

Joan Gil, PhD, Llorenç Coll-Mulet, BD, Daniel Iglesias-Serret, PhD, Antonio F. Santidrián, BD, Esther Castaño, PhD, Clara Campàs, PhD, Montserrat Barragán, PhD, Ana M. Cosialls, BD, Mercé De Frias, BD, Alberto Fernández de Sevilla, MD, PhD, Alicia Domingo, MD, Lyubomir T. Vassilev, PhD, Gabriel Pons, MD, PhD

Blood (2005) 106 (11): 5040.

https://doi.org/10.1182/blood.V106.11.5040.5040

Published: 2005

Journal Articles

Minimal Residual Disease (MRD) Analysis in Acute Myeloid Leukemia (AML) with Favorable Cytogenetics [t(8;21) and inv(16)] by Real Time PCR(RT-PCR) and Flow Cytometry (FC).

Blood (2004) 104 (11): 2989.

https://doi.org/10.1182/blood.V104.11.2989.2989

Published: 2004

Journal Articles

Differential Cytogenetic Pattern of Splenic Marginal Zone B-Cell Lymphoma CD5 Positive Versus CD5 Negative. Preliminary Results.

Eva Gimeno, Marta Salido, Isabel Granada, Blanca Espinet, Encarnacion Perez-Vila, Antonio Salar, Carles Besses, Mar Bellido, Alicia Domingo, Fuensanta Milla, Sergi Serrano, Soledad Woessner, Lourdes Florensa, Francesc Sole

Blood (2004) 104 (11): 2272.

https://doi.org/10.1182/blood.V104.11.2272.2272

Published: 2004

Journal Articles

Cytogenetic and FISH Study of 92 Patients with Splenic Marginal Zone B-Cell Lymphoma (SMZBCL).

Marta Salido, Francesc Sole, Blanca Espinet, Eva Gimeno, Lourdes Florensa, Isabel Granada, Laura Astier, Alicia Domingo, Manuela Mollejo, Jose A. Martinez-Climent, Juan L. Garcia, Isana Benet, Jesus M. Hernandez, Pedro Martinez, Miguel A. Piris, Encarna Perez-Vila, Soledad Woessner, Elias Campo, Sergio Serrano

Blood (2004) 104 (11): 699.

https://doi.org/10.1182/blood.V104.11.699.699

Published: 2004

NARROW

Eight Years Experience in External Quality Assessment Scheme (EQAS) for Peripheral Blood Morphology

Analysis of Cytogenetic Abnormalities and Their Prognostic Impact in a Series of 145 Mantle Cell Lymphoma Cases with An Abnormal Karyotype.

MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells

MDM2 Antagonists Activate p53 and Synergize with Genotoxic Drugs To Induce Apoptosis in B-Cell Chronic Lymphocytic Leukemia Cells but Not in T Cells.

Minimal Residual Disease (MRD) Analysis in Acute Myeloid Leukemia (AML) with Favorable Cytogenetics [t(8;21) and inv(16)] by Real Time PCR(RT-PCR) and Flow Cytometry (FC).

Differential Cytogenetic Pattern of Splenic Marginal Zone B-Cell Lymphoma CD5 Positive Versus CD5 Negative. Preliminary Results.

Cytogenetic and FISH Study of 92 Patients with Splenic Marginal Zone B-Cell Lymphoma (SMZBCL).

Email alerts

ASH Publications

American Society of Hematology

Eight Years Experience in External Quality Assessment Scheme (EQAS) for Peripheral Blood Morphology

Analysis of Cytogenetic Abnormalities and Their Prognostic Impact in a Series of 145 Mantle Cell Lymphoma Cases with An Abnormal Karyotype.

MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells

MDM2 Antagonists Activate p53 and Synergize with Genotoxic Drugs To Induce Apoptosis in B-Cell Chronic Lymphocytic Leukemia Cells but Not in T Cells.

Minimal Residual Disease (MRD) Analysis in Acute Myeloid Leukemia (AML) with Favorable Cytogenetics [t(8;21) and inv(16)] by Real Time PCR(RT-PCR) and Flow Cytometry (FC).

Differential Cytogenetic Pattern of Splenic Marginal Zone B-Cell Lymphoma CD5 Positive Versus CD5 Negative. Preliminary Results.

Cytogenetic and FISH Study of 92 Patients with Splenic Marginal Zone B-Cell Lymphoma (SMZBCL).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only